Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

Stopped early

Conditions studied: Growth Hormone Deficiency, Pituitary Tumor

In brief

The purpose of this study is to determine if patients with a history of nonsecreting pituitary adenomas with untreated GH deficient patients have profiles consistent with increased cardiovascular risk compared to patients without GH deficiency who have undergone similar surgery.

Key facts

Study ID

NCT00646308

Run by

Columbia University

People needed

60

Starts

2008-03-01

Expected to finish

2010-03-01

Last updated by the study team

2011-04-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with a history of a nonsecreting pituitary tumor with or without prior pituitary surgery.

You may not qualify if…

• Current use of GH therapy or within the prior 3 months. Pituitary tumor necessitating surgery.

Where it is running

• Columbia University Neuroendocrine Unit — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.